Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F02P9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,601
Award facts
- Contract value 100% obligated
- $14,601.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on December 31, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with a firm fixed price ceiling value of $14,601.37 and an ultimate completion date of January 2, 2026. This is a non-set-aside, competitively awarded contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 running through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, has demonstrated extensive capability in fulfilling federal medical procurement requirements through multiple competitively awarded contracts with the DLA covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across numerous therapeutic domains. The company's role as a prime vendor supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Ozempic, a diabetes medication commonly used in military and veteran healthcare systems, exemplifies the company's continued supply of essential pharmaceutical commodities supporting federal medical supply chains.
Quick answers
Who was awarded contract SPE2DR26F02P9?
SPE2DR26F02P9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F02P9 worth?
The government has obligated $14,601 on SPE2DR26F02P9.
Is contract SPE2DR26F02P9 an order under another contract?
Yes. SPE2DR26F02P9 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F02P9 competed?
The extent of competition for SPE2DR26F02P9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award